BAM
Bell Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,171
| Closed | -$5.75M | – | 65 |
|
|
2024
Q3 | $5.75M | Sell |
29,171
-15,646
| -35% | -$3.08M | 1.05% | 48 |
|
|
2024
Q2 | $9.26M | Buy |
44,817
+6,145
| +16% | +$1.27M | 1.3% | 26 |
|
|
2024
Q1 | $10.5M | Sell |
38,672
-4,767
| -11% | -$1.29M | 1.54% | 25 |
|
|
2023
Q4 | $10.3M | Sell |
43,439
-6,868
| -14% | -$1.62M | 1.57% | 19 |
|
|
2023
Q3 | $9.86M | Buy |
50,307
+4,403
| +10% | +$863K | 1.62% | 19 |
|
|
2023
Q2 | $9.65M | Buy |
45,904
+4,296
| +10% | +$903K | 1.65% | 20 |
|
|
2023
Q1 | $8.4M | Sell |
41,608
-248
| -0.6% | -$50.1K | 1.53% | 27 |
|
|
2022
Q4 | $9.12M | Sell |
41,856
-391
| -0.9% | -$85.2K | 1.71% | 24 |
|
|
2022
Q3 | $8.31M | Buy |
42,247
+2,605
| +7% | +$513K | 1.69% | 29 |
|
|
2022
Q2 | $8.48M | Buy |
39,642
+8,349
| +27% | +$1.79M | 1.67% | 21 |
|
|
2022
Q1 | $8.89M | Buy |
31,293
+6,885
| +28% | +$1.96M | 1.53% | 25 |
|
|
2021
Q4 | $9.2M | Buy |
24,408
+7,983
| +49% | +$3.01M | 1.48% | 32 |
|
|
2021
Q3 | $6.78M | Sell |
16,425
-868
| -5% | -$358K | 1.16% | 46 |
|
|
2021
Q2 | $6.4M | Sell |
17,293
-91
| -0.5% | -$33.7K | 1.25% | 38 |
|
|
2021
Q1 | $5.04M | Sell |
17,384
-4,047
| -19% | -$1.17M | 1.08% | 52 |
|
|
2020
Q4 | $5.36M | Buy |
21,431
+1,104
| +5% | +$276K | 1.17% | 48 |
|
|
2020
Q3 | $4.6M | Sell |
20,327
-4,289
| -17% | -$971K | 1.15% | 49 |
|
|
2020
Q2 | $4.29M | Sell |
24,616
-17,197
| -41% | -$3M | 1.16% | 50 |
|
|
2020
Q1 | $5.28M | Buy |
41,813
+8,749
| +26% | +$1.1M | 1.64% | 25 |
|
|
2019
Q4 | $5.05M | Buy |
+33,064
| New | +$5.05M | 1.3% | 39 |
|